Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes (2024)

Peer-Reviewed Study · Chaumeau V; Wasisakun P; Watson JA; Oo T; Aryalamloed S; Sue MP; Htoo GN; Tha NM; Archusuksan L; Sawasdichai S; Gornsawun G; Mehra S; White NJ; Nosten FH · July 26, 2024

Chaumeau V et al., 2024-07-26: Ex vivo membrane-feeding study with blood from vivax malaria patients in Thailand showing methylene blue blocks P. vivax transmission far more strongly than artesunate, while chloroquine barely blocks it.

Gametocyte exposures to artesunate and methylene blue reduced the mean oocyst count 469-fold (95% CI: 345 to 650) and 1,438-fold (95% CI: 970 to 2,064), respectively.

Abstract

Chaumeau V et al., 2024-07-26: Ex vivo membrane-feeding study with blood from vivax malaria patients in Thailand showing methylene blue blocks P. vivax transmission far more strongly than artesunate, while chloroquine barely blocks it. Study type: ex vivo direct membrane-feeding assay on patient blood with Bayesian modelling; vivax malaria patients, Thai-Myanmar border (SMRU). MB incubated with blood specimens; concentrations not given in abstract; no human dosing. Comparator: untreated control feeds, chloroquine, artesunate. Funding: Wellcome Trust 220211. Competing interests: 'The authors declare no conflict of interest.' Study type: lab.